Coppell Advisory Solutions’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52
| Closed | -$37 | – | 1206 |
|
|
2024
Q4 | $37 | Hold |
52
| – | – | ﹤0.01% | 1945 |
|
|
2024
Q3 | $83 | Hold |
52
| – | – | ﹤0.01% | 1807 |
|
|
2024
Q2 | $87 | Buy |
+52
| New | +$87 | ﹤0.01% | 1725 |
|
|
2023
Q4 | $80 | Sell |
52
-61
| -54% | -$94 | ﹤0.01% | 1658 |
|
|
2023
Q3 | $216 | Buy |
113
+61
| +117% | +$117 | ﹤0.01% | 1107 |
|
|
2023
Q2 | $113 | Buy |
+52
| New | +$113 | ﹤0.01% | 1371 |
|
|
2023
Q1 | – | Sell |
-113
| Closed | -$216 | – | 704 |
|
|
2022
Q4 | $216 | Buy |
+113
| New | +$216 | ﹤0.01% | 1108 |
|